B. Lynne Parshall, Esq.
Ms. Parshall is a Director and a strategic advisor for Ionis Pharmaceuticals. She served as the Chief Financial Officer and as the Chief Operating officer for Ionis for over 26 years where she was responsible for overseeing the operations of finance, legal, patents, manufacturing, information technology, regulatory and alliance management, health and safety, facilities, corporate communications, and business and corporate development. Ms. Parshall joined Ionis in November 1991. Ms. Parshall was instrumental in forging collaborative relationships between Ionis and Biogen, Astra Zeneca, Novartis, Glaxo Smith Kline, and others.
Ms. Parshall is a member of Ionis’ Board of Directors, along with the Operating Committee, Development Management Committee, and Research Management Committee.
Ms. Parshall is currently on the Board of Akcea Therapeutics, Inc. and Cytokinetics, Inc., where she is the Chairman of the Audit Committee.
Previously, Ms. Parshall was a Partner with the firm of Cooley Godward LLP, now Cooley LLP, where she represented several health care companies in a general practice specializing in corporate partnering and other technology-based transactions.
Ms. Parshall received her J.D. at Stanford Law School, Stanford, California and her B.A. from Harvard University, Cambridge, Massachusetts. Ms. Parshall is also a member of the Licensing Executives Society and a member of the American, California, and San Diego bar associations.